EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TAB2 Promotes Immune Escape and Chemoresistance Through NF ‐ κB Pathway Activation in Cervical Cancer

Man Wu, Yingying Zhang, Xuanhui Wang, Yijia Zhou iD

Journal of Cellular and Molecular Medicine · 2025

DOI: 10.1111/jcmm.70522 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Man Wu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory for Reproductive Medicine of Guangdong Province, Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: NF-kappa B, Uterine Cervical Neoplasms, Drug Resistance, Neoplasm, Adaptor Proteins, Signal Transducing. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cervical cancer (CC) remains a major health challenge with high mortality rates due to chemoresistance and immune escape. However, the underlying mechanisms remain unclear. We investigated the role of TAB2 in CC using cisplatin‐resistant and parental cell lines. Cell proliferation, migration, sphere formation and T cell‐mediated killing assays were performed. Western blot and qRT‐PCR analysed protein and mRNA expression. NF‐κB pathway involvement was examined using the BAY 11–7082 inhibitor. TAB2 expression was significantly elevated in cisplatin‐resistant CC cells. TAB2 overexpression promoted chemoresistance and immune escape through NF‐κB pathway activation. Conversely, TAB2 knockdown or NF‐κB inhibition sensitised resistant cells to cisplatin and enhanced T cell‐mediated killing. The resistant phenotype could be rescued by restoring PD‐L1 expression. Our findings reveal TAB2 as a critical regulator of both chemoresistance and immune escape in CC through NF‐κB pathway activation. This suggests TAB2 as a potential therapeutic target for overcoming treatment resistance in CC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-kappa BUterine Cervical NeoplasmsDrug Resistance, NeoplasmAdaptor Proteins, Signal TransducingSignal TransductionTumor EscapeHumansFemaleCisplatinCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticB7-H1 AntigenCell Movement

Stichwörter der Autor:innen

NF‐κB pathwayTAB2cervical cancerchemoresistanceimmune escape

Substanzen

NF-kappa BAdaptor Proteins, Signal TransducingCisplatinTAB2 protein, humanB7-H1 AntigenCD274 protein, human

Autor:innen und Institutionen

  • Key Laboratory for Reproductive Medicine of Guangdong Province, Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Department of Obstetrics and Gynecology, Center for Reproductive Medicine, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guang…
  • Department of Obstetrics and Gynecology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Guangdong Provincial Clinical Research Center for Obstetrical and Gynecological Diseases, Guangzhou, Guangdong, China.

ORCID-Profile: Yijia Zhou

Zitieren

APA

Wu, M., Zhang, Y., Wang, X., & Zhou, Y. (2025). TAB2 Promotes Immune Escape and Chemoresistance Through NF ‐ κB Pathway Activation in Cervical Cancer. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70522

Vancouver

Wu M, Zhang Y, Wang X, Zhou Y. TAB2 Promotes Immune Escape and Chemoresistance Through NF ‐ κB Pathway Activation in Cervical Cancer. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70522

BibTeX
@article{Wu2025,
  author = {Wu, Man and Zhang, Yingying and Wang, Xuanhui and Zhou, Yijia},
  title = {TAB2 Promotes Immune Escape and Chemoresistance Through NF ‐ κB Pathway Activation in Cervical Cancer},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2025},
  doi = {10.1111/jcmm.70522}
}
Kostenlos starten →